-
-
-
-
-
-
-
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Moderna (MRNA) Issues 2024 Shareholders Letter
-
-
-
-
-
-
-
Dow futures fall 90 pts; banking turmoil continues after Fed hike
-
-
-
-
-
-
-
Moderna (MRNA) Announces Advances Across mRNA Pipeline and Provides Business Update
-
-
-
-
-
-
-
Takeda (TAK) to Transfer Spikevax Japan Marketing Authorization to Moderna (MRNA)
-
-
-
-
-
-
-
Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years
-
-
-
-
-
-
-
Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

